5 ePosters
Session Name- SaaG e-Posters: Improving risk estimation: lessons from coagulation, thrombosis, and miRNAs
Filtered By
- SaaG e-Posters: Improving risk estimation: lessons from coagulation, thrombosis, and miRNAs
Sort By
3. DYSLIPIDEMIA AND RISK FACTORS || 3.1 Epidemiology of cardiovascular diseases and risk factors
216 - Type 2 Diabetes and Different Manifestations of Pre-Existing Cardiovascular Disease as Predictors of Specific Cardiovascular Events (ID 457)
Session Name
SaaG e-Posters: Improving risk estimation: lessons from coagulation, thrombosis, and miRNAs
Presentation Topic
3.1 Epidemiology of cardiovascular diseases and risk factors
Presenter
Authors
- Christoph H Saely, Liechtenstein
- Alexander Vonbank, Austria
- Christine F. Heinzle, Austria
- Daniela Zanolin-Purin, Austria
- Barbara Larcher, Austria
- Arthur Mader, Austria
- Simon Sternbauer, Austria
- Marc Schindewolf, Switzerland
- Iris Baumgartner, Switzerland
- Andreas Leiherer, Austria
- Axel Muendlein, Austria
- Heinz Drexel, Austria
3. DYSLIPIDEMIA AND RISK FACTORS || 3.13 Genomics, GWAS and population genetics; Mendelian randomization
217 - The effect of rs12617336 and rs17574 DPP-4 polymorphisms in hypoalphalipoproteinemia and subclinical atherosclerosis. Results from the GEA Mexican study. (ID 423)
Session Name
SaaG e-Posters: Improving risk estimation: lessons from coagulation, thrombosis, and miRNAs
Presentation Topic
3.13 Genomics, GWAS and population genetics; Mendelian randomization
Presenter
3. DYSLIPIDEMIA AND RISK FACTORS || 3.2 Epidemiology of dyslipidemias
213 - Low-density lipoprotein cholesterol levels with the lowest all-cause mortality: 108,243 individuals in a contemporary population-based study (ID 875)
Session Name
SaaG e-Posters: Improving risk estimation: lessons from coagulation, thrombosis, and miRNAs
Presentation Topic
3.2 Epidemiology of dyslipidemias
Presenter
3. DYSLIPIDEMIA AND RISK FACTORS || 3.8 Novel risk factors and biomarkers
/thumbnails/0.png)
214 - The Ceramide-Based Coronary Event Risk Test (CERT) Predicts Cardiovascular Mortality in Cardiovascular Disease Patients with Type 2 Diabetes as well as in Those Without Diabetes (ID 402)
Session Name
SaaG e-Posters: Improving risk estimation: lessons from coagulation, thrombosis, and miRNAs
Presentation Topic
3.8 Novel risk factors and biomarkers
Presenter
4. CLINICAL VASCULAR DISEASE || 4.12 Prevention and treatment of cardiovasculardisease; miscellaneous
/thumbnails/0.png)
215 - Impact of LDL formula and apo B quantification on UK PCSK9i and ESC/EAS treatment thresholds in patients being investigated for familial combined hyperlipidaemia (ID 285)
Session Name
SaaG e-Posters: Improving risk estimation: lessons from coagulation, thrombosis, and miRNAs
Presentation Topic
4.12 Prevention and treatment of cardiovasculardisease; miscellaneous
Presenter